Cybin Inc.
CYBN | AMEX
$8.28
+$0.10 (+1.22%)
At close: Jan 02, 2026, 04:00 PM ET
+1.22%
(1D)No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Market Cap $413.02M
1D Range
8.14 8.38
52W Range
4.81 10.72
Valuation (TTM)
PE -2.78
PB 2.97
EV/EBITDA -3.22
Valuation (NTM)
Forward PE N/A
Forward PEG 0.17
Price Target N/A
Cash Flow
FCF Yield -18.1%
SBC Adj. FCF Yield -19.2%
SBC Impact -6.0%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
-100.0%
Dil EPS 3Y | 5Y -75.6% |
-62.3%
FCF 3Y | 5Y -36.5% |
-27.1%
Returns
ROA -28.6%
ROE -41.4%
ROIC -32.1%
Financial Health
Net Cash
C$54.86M
Current Ratio 8.58
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Cybin Inc. is a biopharmaceutical firm dedicated to pioneering treatments that leverage psychedelic compounds. Its research and development portfolio encompasses several key candidates: CYB003, a modi...
Sector Healthcare
Industry Biotechnology
Employees 50
IPO Date Sep 13, 2019
Website www.cybin.com
Fiscal Year April - March
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove CYBN